1. Home
  2. HTCR vs SPRO Comparison

HTCR vs SPRO Comparison

Compare HTCR & SPRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HTCR
  • SPRO
  • Stock Information
  • Founded
  • HTCR 2009
  • SPRO 2013
  • Country
  • HTCR Japan
  • SPRO United States
  • Employees
  • HTCR N/A
  • SPRO N/A
  • Industry
  • HTCR EDP Services
  • SPRO Biotechnology: Pharmaceutical Preparations
  • Sector
  • HTCR Technology
  • SPRO Health Care
  • Exchange
  • HTCR Nasdaq
  • SPRO Nasdaq
  • Market Cap
  • HTCR 48.1M
  • SPRO 45.7M
  • IPO Year
  • HTCR 2022
  • SPRO 2017
  • Fundamental
  • Price
  • HTCR $0.84
  • SPRO $0.84
  • Analyst Decision
  • HTCR
  • SPRO Buy
  • Analyst Count
  • HTCR 0
  • SPRO 4
  • Target Price
  • HTCR N/A
  • SPRO $5.00
  • AVG Volume (30 Days)
  • HTCR 87.3K
  • SPRO 112.8K
  • Earning Date
  • HTCR 05-13-2025
  • SPRO 03-27-2025
  • Dividend Yield
  • HTCR 4.67%
  • SPRO N/A
  • EPS Growth
  • HTCR N/A
  • SPRO N/A
  • EPS
  • HTCR 0.23
  • SPRO N/A
  • Revenue
  • HTCR $30,290,930.00
  • SPRO $47,977,000.00
  • Revenue This Year
  • HTCR $53.30
  • SPRO N/A
  • Revenue Next Year
  • HTCR N/A
  • SPRO N/A
  • P/E Ratio
  • HTCR $3.69
  • SPRO N/A
  • Revenue Growth
  • HTCR 47.63
  • SPRO N/A
  • 52 Week Low
  • HTCR $0.55
  • SPRO $0.73
  • 52 Week High
  • HTCR $3.38
  • SPRO $1.81
  • Technical
  • Relative Strength Index (RSI)
  • HTCR 40.92
  • SPRO 54.74
  • Support Level
  • HTCR $0.95
  • SPRO $0.75
  • Resistance Level
  • HTCR $1.10
  • SPRO $0.80
  • Average True Range (ATR)
  • HTCR 0.09
  • SPRO 0.04
  • MACD
  • HTCR 0.01
  • SPRO 0.01
  • Stochastic Oscillator
  • HTCR 42.86
  • SPRO 46.08

About HTCR Heartcore Enterprises Inc.

HeartCore Enterprises Inc is a software development company. It provides software through two business units. The first business unit includes a customer experience management business that has been in existence for 12 years. The customer experience management platform includes marketing, sales, service and content management systems, as well as other tools and integrations, that enable companies to attract and engage customers throughout the customer experience. It also provides education, services and support to help customers be successful with the CXM Platform. The second business unit, its DX division, is a digital transformation business that provides customers with robotics process automation, process mining and task mining to accelerate the digital transformation of enterprises.

About SPRO Spero Therapeutics Inc.

Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, tebipenem pivoxil hydrobromide or tebipenem HBr, is designed to be an oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections. It is also developing SPR720, a novel oral antibiotic designed for the treatment of a rare, orphan disease caused by pulmonary non-tuberculous mycobacterial infections, or NTM disease. Besides, it is also focused on SPR206, a next-generation polymyxin investigational product candidate, being developed as an IV-administered medicine to treat MDR Gram-negative infections in the hospital.

Share on Social Networks: